<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have demonstrated increased levels of DNA double-strand breaks (DSBs) and activation of the DNA damage response (DDR) in <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> during <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
<SENT sid="1" pm="."><plain>Those observations have not been fully elucidated using paraffin-embedded tissues of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aims of this study were to analyze the presence of DSBs and DDR activation mediated by p53-binding protein 1 (53BP1), which is a conserved checkpoint and DNA repair protein, and to clarify their association with <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> progression </plain></SENT>
<SENT sid="3" pm="."><plain>We used immunohistochemical staining to investigate the expression of γH2AX, a sensitive marker for DSBs, in 152 colorectal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (46 low-grade <z:mpath ids='MPATH_270'>adenomas</z:mpath>, 25 high-grade <z:mpath ids='MPATH_270'>adenomas</z:mpath>, 25 intramucosal <z:mp ids='MP_0002038'>carcinomas</z:mp>, and 56 invasive <z:mp ids='MP_0002038'>carcinomas</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>The colocalization of γH2AX and 53BP1, which is strongly associated with the DSB repair process, was analyzed using double-label immunofluorescence </plain></SENT>
<SENT sid="5" pm="."><plain>Elevated γH2AX expression was identified in 16 (16.7%) of 96 intramucosal <z:hpo ids='HP_0002664'>neoplasias</z:hpo> and in 19 (33.9%) of 56 invasive <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Double-label immunofluorescence occasionally revealed cells, particularly in invasive <z:mp ids='MP_0002038'>carcinoma</z:mp>, with γH2AX foci that did not colocalize with 53BP1 </plain></SENT>
<SENT sid="7" pm="."><plain>The percentage of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with γH2AX foci that colocalized with 53BP1 was significantly lower in invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> than in intramucosal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (median percentage, 54.8% and 88.5%, respectively; P = .001) </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, the number of cells with DSBs increases in intramucosal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>The decreasing number of cells with colocalization of γH2AX and 53BP1 during the progression from intramucosal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> to invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> suggests that DDR, at least mediated by 53BP1, is inefficient during the process of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> invasion </plain></SENT>
</text></document>